Cropshree Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.94 Cr
About Cropshree Lifesciences
Cropshree Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 April 2022 (Two years and ten months 1 days old ). Its registered office is in Nadia, West Bengal, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹6.94 Cr.
Bijay Banerjee, Amrita Ghosh, and Shivam Ghosh serve as directors at the Company.
Company Details
- Location
Nadia, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230WB2022PTC253299
- Company No.
253299
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Cropshree Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bijay Banerjee  | Director | 25-Apr-2022 | Current |
| Amrita Ghosh | Director | 25-Apr-2022 | Current |
| Shivam Ghosh | Director | 29-Apr-2023 | Current |
Financial Performance of Cropshree Lifesciences.
Cropshree Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cropshree Lifesciences?
Unlock access to Cropshree Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹6.94 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 6.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2022 | State Bank Of India | ₹6.94 Cr | Open |
How Many Employees Work at Cropshree Lifesciences?
Unlock and access historical data on people associated with Cropshree Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cropshree Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropshree Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.